Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Early Life Wheezing
NCT00115297Phase 3Completed
- Sponsor
- University of Massachusetts
- Start
- Sep 2004
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Montelukast with Placebo (2 arms). Primary endpoint: Number of Wheezing-free Days of Infant (Observed by Primary Caregiver) at 56 days. Started Sep 2004; status: completed.
02
Drugs
montelukast
Beyond the preview
Go deeper on NCT00115297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115297.